Pharmaceutical drug delivery refers to the process of administering drugs into a patient’s body to achieve a therapeutic effect or treatment. Drug delivery systems can be categorized into two main types: conventional and novel. The conventional drug delivery system encompasses commonly used methods of delivering drugs through different routes, including oral (by mouth), topical (via the skin), and transmucosal (nasal, buccal, sublingual, vaginal, rectal, and ocular). These approaches are designed to alter how drugs are absorbed, distributed, metabolized, and eliminated in order to enhance patient convenience.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @
https://www.coherentmarketinsights.com/insight/request-sample/2633
Top Companies Associated With The Pharmaceutical Drug Delivery Market Report Are:
Johnson and Johnson, Merck & Co, Inc., Bayer AG, Pfizer, Inc., Novartis AG, Sanofi, Antares Pharma, Inc., Accord Healthcare, Inc., Abbott, and GSK.
Global Pharmaceutical drug Delivery Market Drivers
The growth of the global pharmaceutical drug delivery market is anticipated to be driven by the increasing approval of novel drugs by the U.S. Food and Drug Administration (FDA). An illustrative example is the approval of Duobrii in April 2019, a medication containing halobetasol propionate and tazarotene, designed for treating plaque psoriasis. The manufacturer behind this product is Ortho Dermatologics Company.
Furthermore, the market is expected to receive a boost from the introduction of new pharmaceutical products. For instance, in August 2018, Sanofi Genzyme launched Aubagio, a medication targeting multiple sclerosis. Aubagio offers the advantage of being a once-a-day treatment, enhancing convenience for patients.
Additionally, Pfizer made a significant contribution to the market in April 2019 by introducing trastuzumab (marketed as trazimera). This drug addresses the treatment of metastatic HER2-positive breast cancer and HER2-positive metastatic gastric cancer. These innovative products are poised to propel the global pharmaceutical drug delivery market forward.
Detailed Segmentation:
By Route of Administration
- Oral Drug Delivery
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-Solid Oral Drugs
- Topical Drug Delivery
- Liquid Formulation
- Semi-Solid Formulation
- Solid Formulation
- Transdermal Products
- Pulmonary Drug Delivery
- Metered-Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Drops
- Nasal Sprays
- Nasal Powders
- Nasal Gels
- Transmucosal Drug Delivery
- Oral Formulations
- Others
- Injectable Drug Delivery
- Conventional Injection Devices
- Self-Injection Devices
- Others
- Liquid Formulations
- Semi-Solid Formulations
- Ocular Devices
- Implantable Drug Delivery
- Active Implantable Drug Delivery
- Passive Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers/ Clinics
- Diagnostic Centers
- Others
Global Pharmaceutical Drug Delivery Market Restraints:
The growth of the global pharmaceutical drug delivery market could face hindrances due to drug shortages. An example of this is the shortage of Buspirone HCL Tablets – 7.5mg, manufactured by Accord Healthcare Inc., as highlighted in a New York Times report from February 2019. This scarcity resulted from a heightened demand for the drug, primarily used for anxiety treatment.
Furthermore, the market could experience setbacks due to regulatory actions. In September 2018, the Union Health Ministry of India imposed a ban on 328 Fixed Dose Composition (FDC) drugs due to concerns surrounding their irrational use. Among the prohibited drugs were combinations such as Aceclofenac (SR) + Paracetamol 750, Aceclofenac + Paracetamol + Famotidine, and naproxen plus paracetamol. These bans have the potential to impact the growth trajectory of the global pharmaceutical drug delivery market.
Purchase This Premium Report And Get Up To 25 % Off @
https://www.coherentmarketinsights.com/insight/buy-now/2633
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Pharmaceutical Drug Delivery Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Pharmaceutical Drug Delivery Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Global Pharmaceutical Drug Delivery Market- Regional Analysis:
North America: North America holds a significant share in the global pharmaceutical drug delivery market. The region’s advanced healthcare infrastructure, substantial research and development activities, and strategic collaborations between pharmaceutical companies and research institutions contribute to its dominance. The presence of key pharmaceutical players and a well-established regulatory framework also foster market growth.
Europe: Europe follows closely, boasting a robust pharmaceutical industry and a strong emphasis on research and innovation. Countries like Germany, France, and the United Kingdom are major contributors to the market. The region’s focus on personalized medicine, coupled with favorable government policies, propels the pharmaceutical drug delivery market’s expansion.
Asia-Pacific: The Asia-Pacific region is emerging as a vital player in the pharmaceutical drug delivery market. Increasing healthcare investments, rising disposable incomes, and a large patient pool fuel the demand for advanced drug delivery systems. Countries like China and India are prominent growth centers, with a burgeoning pharmaceutical sector and a growing emphasis on improving healthcare infrastructure.
Latin America: Latin America demonstrates steady growth potential in the pharmaceutical drug delivery market. Developing economies, coupled with rising healthcare awareness, contribute to market growth. Brazil and Mexico stand out as key markets in this region, driven by increasing healthcare expenditure and a growing prevalence of chronic diseases.
We Offer Customized Report, Click @
https://www.coherentmarketinsights.com/insight/request-customization/2633
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Explore More Related Insights:
Anti osteoporosis and fracture healing market
India immune oncology drugs market
Chronic liver diseases therapeutics market
Uae heart failure drugs treatment market
Hemoglobinopathy treatment drugs market
North america companion animal drugs market
Colombia wound care biologics market
Anti osteoporosis and fracture healing market
Liver diseases therapeutics market
Ischemia reperfusion injury therapeutics market
North america and europe age related macular degeneration therapeutics market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter